Form 4: Septerna Director Jake Simson Granted 16,623 Stock Options

Septerna, Inc. Director Jake Simson was granted 16,623 stock options with an exercise price of $10.24, vesting upon the earlier of June 17, 2026, or the company's next annual meeting.

Summary

• Jake Simson, a Director and 10% Owner of Septerna, Inc. (SEPN), was granted 16,623 stock options.
• The transaction date for the option grant was June 17, 2025.
• The exercise price for these stock options is $10.24 per share.
• The shares underlying the stock option will vest in full upon the earlier of June 17, 2026, or Septerna's next annual meeting of stockholders, contingent on Mr. Simson's continued service.
• The options have an expiration date of June 16, 2035.
• Mr. Simson holds these options for the benefit of R.A. Capital Healthcare Fund, L.P. and R.A. Capital Nexus Fund III, L.P., under an arrangement with RA Capital Management, L.P.
• Mr. Simson is obligated to turn over any net cash or stock received upon exercise to RA Capital Management, L.P., which will offset advisory fees owed by the funds.
• Due to this arrangement, Mr. Simson disclaims beneficial ownership of the option and the underlying common stock.

Sentiment

Score: 6

Explanation: The sentiment is mildly positive. While the transaction itself is routine, the grant of options to a director generally signals continued commitment and aligns interests with shareholders. The disclaimer of beneficial ownership is a neutral, albeit important, detail regarding the ultimate recipient of the economic benefit.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders, incentivizing long-term performance.
• The vesting schedule encourages continued service and commitment from the director.

Negatives

• The reporting person, Jake Simson, disclaims beneficial ownership of the options and underlying common stock, indicating that the direct financial benefit from these options will accrue to RA Capital Management's funds rather than personally to the director.

Future Outlook

The stock options are set to vest in full upon the earlier of June 17, 2026, or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service.

Industry Context

This Form 4 filing represents a routine disclosure of an insider transaction, specifically an equity grant to a director, which is a common practice in publicly traded companies to align management and director incentives with shareholder interests. Such grants are standard compensation components in the biotechnology or pharmaceutical sector, where Septerna, Inc. likely operates.

Related Party Transactions

• Jake Simson holds the stock options for the benefit of R.A. Capital Healthcare Fund, L.P. and R.A. Capital Nexus Fund III, L.P., under an arrangement with RA Capital Management, L.P. Mr. Simson is obligated to turn over any net cash or stock received upon exercise to RA Capital Management, L.P., which will offset advisory fees owed by the funds. This arrangement constitutes a related party transaction concerning the beneficial ownership of the options.

Stakeholder Impact

• Shareholders: The grant of options to a director can be seen as a positive, aligning the director's long-term interests with shareholder value creation, even if the direct economic benefit flows to related funds.
• Employees: No direct impact mentioned.

Next Steps

• The stock options will vest upon the earlier of June 17, 2026, or the Issuer's next annual meeting of stockholders.
• The Reporting Person may exercise the options at any time after vesting until the expiration date of June 16, 2035.

Key Dates

Keywords

Septerna Inc., SEPN, Stock Option, Insider Transaction, Form 4, Equity Grant, Director Compensation, Beneficial Ownership, RA Capital Management